尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Reed Michael Lee, 董事. Director active across 2 companies, notably Nutex Health, Inc.. Aggregated, 4 disclosures have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €4k. History available since 9 May 2022. The latest transaction was disclosed on 31 July 2026 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Michael Lee Reed is a Director at Nutex Health, Inc. In this role, he contributes to the governance of the company, ensuring that strategic decisions align with growth objectives. His experience in the healthcare sector allows him to make significant contributions to Nutex Health's management. Michael Reed is committed to promoting innovation and expansion within the company.